ES2036526T3 - Composiciones de interferon. - Google Patents

Composiciones de interferon.

Info

Publication number
ES2036526T3
ES2036526T3 ES198686309134T ES86309134T ES2036526T3 ES 2036526 T3 ES2036526 T3 ES 2036526T3 ES 198686309134 T ES198686309134 T ES 198686309134T ES 86309134 T ES86309134 T ES 86309134T ES 2036526 T3 ES2036526 T3 ES 2036526T3
Authority
ES
Spain
Prior art keywords
interferon
compositions
interferon compositions
tumors
viruses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198686309134T
Other languages
English (en)
Spanish (es)
Inventor
Paul Jason Leibowitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ES2036526T3 publication Critical patent/ES2036526T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/811—Interferon

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES198686309134T 1985-12-11 1986-11-21 Composiciones de interferon. Expired - Lifetime ES2036526T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/807,887 US4806347A (en) 1985-12-11 1985-12-11 Interferon combinations

Publications (1)

Publication Number Publication Date
ES2036526T3 true ES2036526T3 (es) 1993-06-01

Family

ID=25197366

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198686309134T Expired - Lifetime ES2036526T3 (es) 1985-12-11 1986-11-21 Composiciones de interferon.

Country Status (7)

Country Link
US (1) US4806347A (OSRAM)
EP (1) EP0225759B1 (OSRAM)
JP (1) JPS62145029A (OSRAM)
AT (1) ATE76579T1 (OSRAM)
DE (1) DE3685484D1 (OSRAM)
ES (1) ES2036526T3 (OSRAM)
GR (1) GR3005362T3 (OSRAM)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2039276T3 (es) * 1987-01-20 1993-09-16 Schering Corporation Uso de una combinacion de interferon gamma e interferon alfa para la preparacion de un medicamento para el tratamiento de ciertas leucemias.
US6685933B1 (en) 1998-07-28 2004-02-03 The United States Of America As Represented By The Department Of Health And Human Services Interferon α hybrids
US8147822B1 (en) * 1999-09-17 2012-04-03 Wellstat Biologics Corporation Oncolytic virus
DE60041210D1 (de) 1999-09-17 2009-02-05 Wellstat Biologics Corp Onkolytisches Virus
US20030129162A1 (en) * 2000-09-12 2003-07-10 Lau Allan S. Compositions comprising mixtures of therapeutic proteins and methods of producing the same
US20050013801A1 (en) * 2001-10-05 2005-01-20 Hsu Henry H. Methods of treating liver fibrosis and hepatitis c virus infection
WO2004078194A1 (en) * 2003-02-28 2004-09-16 Intermune, Inc. Interferon drug therapy for the treatment of viral diseases and liver fibrosis
NZ541951A (en) 2003-03-07 2008-03-28 Robarts Res Inst Use of myxoma virus for the therapeutic treatment of cancer and chronic viral infection
TW201245229A (en) 2003-10-14 2012-11-16 Hoffmann La Roche Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of HCV replication
CA2600675C (en) 2005-03-07 2015-12-15 Robarts Research Institute Use of a combination of myxoma virus and rapamycin for therapeutic treatment
JP5249028B2 (ja) 2005-07-25 2013-07-31 インターミューン・インコーポレーテッド Ｃ型肝炎ウイルス複製の新規大環状阻害剤
GEP20104956B (en) 2005-10-11 2010-04-12 Array Biopharma Inc Compounds for inhibiting hepatitis c viral replication and use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES506955A0 (es) * 1980-11-10 1983-02-01 Genentech Inc Un procedimiento para producir un polipeptido antiviral.
US4456748A (en) * 1981-02-23 1984-06-26 Genentech, Inc. Hybrid human leukocyte interferons
US4414150A (en) * 1980-11-10 1983-11-08 Genentech, Inc. Hybrid human leukocyte interferons
US4678751A (en) * 1981-09-25 1987-07-07 Genentech, Inc. Hybrid human leukocyte interferons
ATE52693T1 (de) * 1982-10-25 1990-06-15 Genentech Inc Synergistische humaninterferonaktivitaet.
EP0146903A3 (en) * 1983-12-19 1987-07-22 Schering Corporation Production of a vector encoding a novel hybrid interferon species

Also Published As

Publication number Publication date
EP0225759A3 (en) 1989-02-08
ATE76579T1 (de) 1992-06-15
GR3005362T3 (OSRAM) 1993-05-24
EP0225759B1 (en) 1992-05-27
EP0225759A2 (en) 1987-06-16
JPS62145029A (ja) 1987-06-29
DE3685484D1 (OSRAM) 1992-07-02
US4806347A (en) 1989-02-21

Similar Documents

Publication Publication Date Title
RU94022480A (ru) Способ лечения гепатита, композиция, усиливающая ин виво инактивацию вируса гепатита с, препарат для лечения гепатита с
IL78553A (en) Therapeutic compositions of phosphonylmethoxyalkyl adenines
FI884013A0 (fi) Konjugat av cytokiner med immunoglobuliner.
ES541103A0 (es) Procedimiento de obtencion de una composicion para el trata-miento de infecciones virales
ES2123064T3 (es) Uso de melatonina en pequeñas dosis orales como somnifero.
ES2180792T3 (es) Acidos linoleicos conjugados para atenuar la respuesta alergica.
SE8504945L (sv) Farmaceutiska kompositioner innehallande antracyklinglykosider
ATE182271T1 (de) Arzneimittel zur behandlung von krebs, aids und viruserkrankungen
DE3688841D1 (de) Schwache interferondosierung fuer die erhoehung der impfstoffwirksamkeit.
ATE197670T1 (de) Parenterales busulfan zur behandlung von malignen krankheiten
ATE125706T1 (de) Diphosphonate enthaltende pharmazeutische zusammensetzungen zur behandlung von arthrosis.
IT8548055A1 (it) Composizioni farmaceutiche per la terapia di sindromi cerebrali involutive e del decadimento mentale
ATE76579T1 (de) Interferon-zusammensetzungen.
DE68903092D1 (de) Laktamimide in der behandlung arzneiresistenter protozoeninjektionen.
DK0531413T3 (da) Et antiviralt præparat indeholdende prostratin
IL88971A0 (en) Disubstituted pyridines,their preparation and pharmaceutical compositions containing them
ES2058451T3 (es) Un metodo para la preparacion de una composicion farmaceutica.
ATE59780T1 (de) Pharmazeutische zusammensetzung zur behandlung von tumoren.
ATE5256T1 (de) Phenylpiperazinderivate von 1,3,4oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel.
ES2037807T3 (es) Medicamentos que contienen en combinacion interferon y 1-desoxi-piperidinosas, procedimiento para su fabricacion y su aplicacion.
ES2103811T3 (es) Terapia antiviral.
ES8704903A1 (es) Un metodo para preparar 6-cloro-2-metil-1h-2,3,4,5-tetrahidro-3-benzazepen-n-oxido.
KR900701311A (ko) 재조합 사람 α-인터페론을 병소내로 투여하여 편평세포 암을 치료하는 방법
ATE26267T1 (de) Pyrimidin-derivate, ausgestattet mit antiviraler wirkung.
DK222988A (da) Farmaceutiske praeparater indeholdende ornithin-decarboxylase-inhibitorer

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 225759

Country of ref document: ES